Sentien Biotechnologies, Inc.
2 clinical trials · Sponsor
◉ Watch Sentien Biotechnologies, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy (NCT04445220) | Sentien Biotechnologies, Inc. | 2020-11-19 |
Track Sentien Biotechnologies, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.